Testosterone has become one of the most marketed molecules in modern medicine. Scroll social media for five minutes and you will encounter ads for "low T" clinics, influencers hawking testosterone boosters, and podcast hosts claiming that declining testosterone is the root cause of everything from brain fog to broken marriages. The global testosterone replacement therapy market is projected to exceed $1.9 billion by 2030, driven largely by direct-to-consumer clinics that have turned a legitimate hormone into a lifestyle brand.

But here is the uncomfortable truth that rarely makes it into the marketing copy: most men walking into those clinics do not have clinical hypogonadism. Many have testosterone levels that are completely normal for their age. And the interventions being sold — from prescription gels to over-the-counter supplements — range from genuinely life-changing (for the right patient) to expensive placebos (for everyone else).

This article cuts through the noise. We will walk through what testosterone actually does in the body, what "normal" levels look like across a lifespan, how to get tested properly, what real testosterone deficiency looks like, what the evidence says about TRT, and which lifestyle factors have measurable effects on your levels. No hype, no sales pitch — just the endocrinology.

What Testosterone Actually Does

Testosterone is a steroid hormone produced primarily in the Leydig cells of the testes. Its production is governed by the hypothalamic-pituitary-gonadal (HPG) axis: the hypothalamus releases GnRH, which signals the pituitary to release LH and FSH, and LH stimulates the testes to produce testosterone. When levels rise, the hypothalamus dials back signaling — a tightly regulated feedback loop.

In the bloodstream, roughly 98% of testosterone is bound to proteins — 60-70% to sex hormone-binding globulin (SHBG) and 30-40% to albumin. Only 1-3% circulates as "free" testosterone, the fraction most readily available to tissues.

Testosterone's roles extend far beyond reproduction:

  • Muscle and bone: Stimulates protein synthesis and promotes bone mineral density. Untreated hypogonadism significantly increases fracture risk.
  • Red blood cells: Stimulates erythropoiesis — which is why erythrocytosis is the most common TRT side effect.
  • Fat metabolism: Favors lean mass over adipose tissue. Hypogonadal men accumulate visceral fat, which further suppresses testosterone through aromatase conversion to estradiol.
  • Mood and cognition: Androgen receptors are distributed throughout the brain. Low testosterone is associated with depressive symptoms, though the relationship is not simply linear.
  • Libido: Necessary for sexual desire, though erectile dysfunction has many causes beyond hormones.
  • Cardiovascular system: Has vasodilatory effects and influences lipid metabolism.

Normal Ranges and Age-Related Decline

This is where the marketing and the medicine diverge.

Most labs define "normal" total testosterone as approximately 264-916 ng/dL (9.2-31.8 nmol/L). The Endocrine Society's 2018 guideline uses 300 ng/dL (10.4 nmol/L) as a reasonable lower threshold. But these ranges span all adult ages — a 25-year-old and a 60-year-old have very different expected levels, and both can be healthy.

The Massachusetts Male Aging Study established that total testosterone declines by approximately 1-2% per year after age 30, and free testosterone falls faster — roughly 2-3% per year — because SHBG increases with age. The European Male Ageing Study (EMAS) confirmed this gradual decline and found that only a small minority of older men with lower levels actually had symptoms consistent with hypogonadism.

The critical point: declining testosterone is a normal part of aging, not a disease. A 55-year-old with a total testosterone of 380 ng/dL may be entirely asymptomatic. Labeling him as "low T" because his level falls below a clinic's marketing threshold does him a disservice.

The Baltimore Longitudinal Study of Aging found enormous individual variation — some men maintain upper-range levels into their 70s, others see drops in their 40s. Genetics, body composition, chronic illness, medications, and lifestyle all play roles.

"Low T" Clinics vs. Real Hypogonadism

Direct-to-consumer testosterone clinics have created a peculiar situation: a condition that endocrinologists carefully diagnose with repeated testing and symptom assessment is now being "diagnosed" via a single blood draw and a questionnaire.

True hypogonadism requires both consistently low testosterone concentrations and specific signs and symptoms. Low levels alone are insufficient, and symptoms alone are insufficient.

Primary hypogonadism (testicular failure): The testes cannot produce adequate testosterone despite elevated LH/FSH signaling. Causes include Klinefelter syndrome, testicular injury, chemotherapy, and mumps orchitis.

Secondary hypogonadism (hypothalamic-pituitary dysfunction): The testes are capable but not receiving adequate signaling. Causes include pituitary tumors, opioid use, severe obesity, and exogenous anabolic steroids.

The most specific symptoms of androgen deficiency include reduced libido, decreased spontaneous erections, gynecomastia, loss of body hair, shrinking testes, infertility, low bone mineral density, and hot flashes.

The less specific symptoms — the ones in every "low T" ad — include fatigue, low mood, poor concentration, increased body fat, and decreased physical performance. These overlap with depression, sleep apnea, hypothyroidism, diabetes, chronic stress, and simple deconditioning.

When a clinic measures your testosterone at 350 ng/dL, calls it "suboptimal," and offers a prescription on the same visit, they are not practicing evidence-based endocrinology. They are selling a product.

How to Get Tested Properly

If you genuinely suspect low testosterone, the testing process matters enormously. The Endocrine Society guideline is specific:

1. Morning blood draw, fasting. Testosterone follows a circadian rhythm, peaking between 7:00 and 10:00 AM and dropping by 20-30% by the afternoon. A 2 PM blood draw could put a perfectly healthy man into the "low" range. Fasting is recommended because glucose and insulin acutely suppress testosterone — a post-meal draw can be misleadingly low.

2. Measure total testosterone first. This is the initial screening test. If the result is below 300 ng/dL (or your lab's lower reference limit), proceed to step 3.

3. Repeat the measurement. A single low reading is not diagnostic. Day-to-day variation in testosterone can be substantial. The Endocrine Society requires at least two separate morning measurements showing low testosterone before making a diagnosis. A study published in the JCEM found that up to 30% of men with an initially low reading had a normal result on repeat testing.

4. Measure free testosterone if total is borderline or SHBG is suspected to be abnormal. Conditions that raise SHBG — aging, liver disease, hyperthyroidism, anticonvulsant use — can lower free testosterone even when total testosterone appears adequate. Conversely, obesity and insulin resistance lower SHBG, making total testosterone look lower than the biologically active fraction would suggest. Calculated free testosterone (using the Vermeulen equation with total testosterone, SHBG, and albumin) is preferred over direct free testosterone immunoassays, which are notoriously inaccurate.

5. Check LH and FSH. These distinguish primary from secondary hypogonadism and guide further workup.

6. Rule out other causes. Prolactin, thyroid function, iron studies (hemochromatosis), cortisol, and metabolic panel should be checked as clinically indicated.

You can log your testosterone blood work results in WatchMyHealth's bloodwork tracker to keep a personal record of your levels over time. Having your historical values in one place makes it much easier to show your doctor a trend rather than relying on memory or scattered lab reports.

TRT: Options, Benefits, and Real Risks

When a man has confirmed hypogonadism with both low levels and genuine symptoms, testosterone replacement therapy can be transformative. The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled trials in men 65 and older with confirmed low testosterone, provided some of the clearest evidence to date.

The TTrials found that one year of testosterone gel treatment, compared to placebo, produced:

  • Significant improvement in sexual desire, erectile function, and sexual activity
  • Modest improvement in walking distance (6-minute walk test) and physical function
  • Improvement in mood and depressive symptoms as measured by the PHQ-9
  • Increased volumetric bone mineral density and estimated bone strength
  • Correction of anemia in men with unexplained anemia of aging

However, the TTrials also found no significant improvement in vitality or cognitive function — two of the most commonly cited reasons men seek TRT.

Delivery Methods

  • Topical gels (AndroGel, Testim): Applied daily. Steady-state levels, but risk of transfer to women and children through skin contact. Most commonly prescribed in the US.
  • Intramuscular injections (testosterone cypionate/enanthate): Every 1-2 weeks. Inexpensive but produces peak-and-trough mood swings. Many clinicians now favor twice-weekly subcutaneous injections to smooth levels.
  • Transdermal patches (Androderm): Applied nightly. Can cause skin irritation.
  • Long-acting injection (testosterone undecanoate/Aveed/Nebido): Every 10 weeks. Most stable levels, but requires in-office administration.
  • Nasal gel (Natesto): 2-3 times daily. No transfer risk, but frequent dosing.

The Risks That Matter

Erythrocytosis: The most common adverse effect. Testosterone stimulates red blood cell production, and hematocrit (the percentage of blood volume occupied by red cells) can rise above 54%, increasing the risk of blood clots, stroke, and cardiovascular events. The Endocrine Society recommends checking hematocrit at baseline, at 3-6 months, then annually. If hematocrit exceeds 54%, the dose should be reduced, treatment paused, or therapeutic phlebotomy performed.

Cardiovascular risk: This has been the most debated area in testosterone medicine. A 2010 trial in elderly men with mobility limitations was stopped early due to excess cardiovascular events in the testosterone group. However, the landmark TRAVERSE trial, published in the New England Journal of Medicine in 2023 — a randomized, double-blind, placebo-controlled trial of 5,246 men aged 45-80 with hypogonadism and established or high risk for cardiovascular disease — found that testosterone treatment was noninferior to placebo for major adverse cardiovascular events over a mean follow-up of 33 months. This largely resolved the controversy for men with true hypogonadism, though the FDA still requires a cardiovascular risk warning on testosterone products.

Fertility suppression: Exogenous testosterone suppresses the HPG axis, dramatically reducing intratesticular testosterone (which is 50-100 times higher than serum levels and essential for spermatogenesis) and often causing azoospermia. TRT is effectively a male contraceptive, though not reliably so. Men who want to preserve fertility should not start TRT without discussing alternatives like clomiphene citrate or human chorionic gonadotropin (hCG) with their endocrinologist.

Prostate concerns: Older concerns about testosterone "causing" prostate cancer have not been borne out by modern evidence. The Endocrine Society guideline states that there is no convincing evidence that TRT increases the risk of prostate cancer. However, TRT is contraindicated in men with known prostate cancer (it can stimulate growth of existing androgen-sensitive tumors) and PSA should be monitored during treatment.

Other risks: Acne, oily skin, worsening of sleep apnea, breast tenderness, testicular atrophy (due to HPG axis suppression), and mood changes.

If you are on TRT, WatchMyHealth's medication tracker can help you log your dosing schedule, while the bloodwork tracker keeps your testosterone, hematocrit, and PSA results organized for easy review at follow-up appointments.

Lifestyle Factors That Actually Move the Needle

For men with borderline levels and vague symptoms, addressing lifestyle factors may resolve the issue without medication.

Sleep

A landmark JAMA study restricted healthy young men to five hours of sleep per night for one week and found daytime testosterone decreased by 10-15% — equivalent to 10-15 years of aging. Testosterone is produced primarily during sleep, peaking during the first REM episode. Chronic sleep deprivation directly impairs this production.

Exercise

Resistance training has the strongest evidence for supporting testosterone. Compound movements (squats, deadlifts) at moderate-to-high intensity produce the largest acute response. However, overtraining has the opposite effect — endurance athletes who train excessively can develop exercise-associated hypogonadism from chronic energy deficit and cortisol elevation. The relationship is an inverted U.

Body Fat

Obesity is one of the strongest predictors of low testosterone. Adipose tissue contains aromatase, which converts testosterone to estradiol. More body fat means lower testosterone and higher estrogen, which signals the hypothalamus to reduce GnRH output — a self-reinforcing cycle.

The EMAS found that weight gain was the single strongest predictor of declining testosterone, more powerful than aging itself. A meta-analysis showed each point of BMI reduction was associated with approximately 2% higher total testosterone. Bariatric surgery has been shown to normalize testosterone in obese hypogonadal men without exogenous hormones.

Stress and Alcohol

Cortisol and testosterone are antagonistic. Chronic stress produces sustained testosterone suppression. Heavy alcohol use is directly toxic to Leydig cells and is a recognized cause of secondary hypogonadism. Moderate consumption (1-2 drinks daily) has modest effects.

Supplements That Don't Work

The testosterone booster supplement market generates billions annually. The science is deeply disappointing.

Tribulus terrestris: Multiple randomized controlled trials have found no effect on testosterone in healthy men. A systematic review in the Journal of Dietary Supplements concluded it does not increase testosterone in humans despite positive animal models.

DHEA: Oral DHEA in men with normal adrenal function has consistently failed to raise testosterone. A two-year RCT in the New England Journal of Medicine found no significant effect on body composition, performance, or quality of life.

D-aspartic acid: A well-designed 3-month trial in resistance-trained men found no difference in testosterone, strength, or body composition versus placebo.

Fenugreek: Small reported increases in free testosterone appear to involve SHBG modulation rather than actual increased production. Clinical significance is debatable.

Ashwagandha: The most promising data — modest increases (10-15%) in stressed or subfertile men, likely via cortisol reduction. But effect sizes are small and would not move a hypogonadal man into normal range.

Zinc and vitamin D: Not "boosters" — they are nutrients whose deficiency impairs testosterone. Correcting a deficiency helps. Supplementing beyond adequate levels does not raise testosterone further.

The bottom line: No supplement reliably raises testosterone to a clinically meaningful degree in men with normal nutritional status. A $60 bottle of "testosterone support" is, based on current evidence, a waste of money.

When to See an Endocrinologist

Not every question about testosterone requires a specialist. Your primary care physician can order and interpret basic testosterone levels, check for common causes of symptoms, and manage straightforward cases. But certain situations warrant referral to an endocrinologist:

  • Testosterone consistently below 200 ng/dL: This suggests more significant pathology, potentially primary hypogonadism or a pituitary disorder.
  • Low LH and FSH with low testosterone: This pattern (secondary hypogonadism) raises concern for pituitary tumors, infiltrative diseases, or other central causes that require imaging and further workup.
  • Elevated prolactin: Hyperprolactinemia can suppress testosterone and may indicate a pituitary prolactinoma.
  • Young men (under 30) with low testosterone: Age-related decline does not explain low levels in young men. Genetic conditions (Klinefelter syndrome), prior chemotherapy, pituitary disease, and other causes need to be excluded.
  • Desire to preserve fertility while treating low testosterone: An endocrinologist or reproductive urologist can guide treatment with clomiphene or hCG rather than exogenous testosterone.
  • Ambiguous or discordant results: When total testosterone is normal but symptoms are present, or when free testosterone calculations do not match the clinical picture, specialist interpretation is valuable.
  • Men on testosterone who develop complications: Rising hematocrit, PSA changes, or unexpected symptoms on TRT warrant specialist co-management.

An endocrinologist will also evaluate the broader hormonal picture — thyroid function, cortisol, growth hormone, and metabolic markers — that a focused "low T" clinic may overlook entirely.

What Your Symptoms Are Actually Telling You

A common scenario: a 42-year-old man feels tired and unmotivated. He visits a testosterone clinic, tests at 410 ng/dL — normal, but below the "optimal" level the clinic promotes. He starts TRT and feels better for a few months. Meanwhile, his sleep apnea goes undiagnosed, his insulin resistance worsens, and his sedentary lifestyle persists. Now he is on a lifelong medication that suppresses his natural production.

The symptoms that drive men to testosterone clinics — fatigue, low mood, reduced libido, poor concentration — are among the most nonspecific in medicine. They overlap with depression, hypothyroidism, sleep disorders, diabetes, and simple deconditioning.

Before attributing symptoms to testosterone, evaluate:

  • Sleep: Consider a sleep study if snoring or daytime sleepiness are present
  • Mental health: Depression (PHQ-9) and anxiety (GAD-7) screening
  • Metabolic health: Fasting glucose, HbA1c, lipid panel
  • Thyroid: TSH and free T4
  • Lifestyle: Exercise, alcohol, diet quality, stress

WatchMyHealth's mood and energy tracking can help you build an objective symptom picture over time. Logging energy, mood, and sleep daily for a few weeks gives your doctor concrete data rather than a vague sense that "something is off."

A Rational Approach

Hypogonadism is real and undertreated. TRT, when properly indicated, can significantly improve quality of life. But the current cultural moment — where normal age-related variation is pathologized and supplements are marketed with claims that contradict evidence — is not serving men well.

A rational framework:

  1. Start with your PCP. Get a comprehensive evaluation, not just a testosterone level.
  2. Test properly: morning, fasting, repeated if low.
  3. Get the full workup if testosterone is genuinely low: LH, FSH, prolactin, thyroid.
  4. Address lifestyle first if poor sleep, excess body fat, or chronic stress are factors. These interventions raise testosterone and improve health broadly.
  5. Understand TRT's commitment: lifelong monitoring of hematocrit, PSA, and symptoms; fertility implications; qualified physician follow-up.
  6. Skip the supplements. No supplement meaningfully raises testosterone in nutritionally adequate men.

Testosterone is not a magic molecule. Sometimes the answer is more sleep, more movement, and less stress. Sometimes it genuinely is TRT. The difference lies in a careful, evidence-based evaluation — not a marketing funnel.